Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.31m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Director/PDMR Shareholding

9 May 2017 17:21

RNS Number : 6577E
Anpario PLC
09 May 2017
Β 

Anpario plc ("Anpario" or "the Company")

Director/PDMR Shareholding

Anpario announces that it was notified today by Karen Prior, CFO of the Company, that on the same day, Karen Prior and her husband, Antony Prior, each sold 5,000 ordinary shares of 23 pence each ("Ordinary Shares") at a price of 320p each. Karen Prior and Antony Prior then each purchased 5,000 Ordinary Shares at a price of 320p within an ISA. Following the disposal and purchase above, there is no change to the ultimate beneficial ownership of Karen Prior in Anpario, being 202,836 Ordinary Shares representing 0.9% of the issued share capital of the Company.

For further information please contact:

Β 

Anpario plc

Richard Edwards, CEO

+44 (0)1909 537 380

Β 

Peel Hunt LLP

Adrian Trimmings, George Sellar

+44 (0)20 7418 8900

Β 

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

Karen Prior and Antony Prior

2

Reason for the notification

a)

Position/status

Β 

CFO and PCA

b)

Initial notification/Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Anpario plc

b)

LEI

213800BZHUIUCH3MCC06

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Sale and purchase of ordinary shares of 23 pence each in the Company ("Ordinary Shares")

Β 

ISIN GB00B3NWT178

Β 

Β 

b)

Nature of the transaction

Β 

Sale and purchase of Ordinary Shares

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

Sold: 320p

Sold: 320p

Purchase: 320p

Purchase: 320p

5,000

5,000

5,000

5,000

d)

Aggregated information

Β 

Price(s)

Volume(s)

320p

20,000

e)

Date of the transaction

Β 

2017-05-09

f)

Place of the transaction

Β 

Β 

London Stock Exchange (XLON), AIM

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHMMGGKVLRGNZM
Date   Source Headline
16th Dec 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
16th Dec 20247:00 amRNSLaunch of SAYE Scheme
29th Nov 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSAcquisition of Bio-Vet Inc.
13th Sep 20247:00 amRNSNotice of Investor Presentation
11th Sep 20247:00 amRNSInterim results
14th Aug 202411:22 amRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSBlock listing Interim Review
25th Jun 20242:34 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Statement
12th Jun 20244:11 pmRNSHolding(s) in Company
24th May 202410:04 amRNSPosting of Annual Report and Notice of AGM
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.